Effect of calcium channel blockers on the serum levels of thyroid hormone

Rimple J. Kaur, Bharati Mehta, Sneha R. Ambwani, Anusuya Gehlot

Abstract


Background: The effect of the calcium channel blockers on the cardiovascular system is implemented judiciously in different conditions related to cardiovascular system such as angina pectoris, hypertension, and in cardiac arrhythmias but the aspect that deals with the impact of blockade of calcium channels in other systems like endocrine system remains eclipsed. These effects generally go unnoticed and the present study was formulated to elucidate the serum T3, T4, TSH levels after administration of calcium channel blockers and to observe the resultant side effect on the endocrine glands, if any by this commonly used group of drugs.

Methods: The study was conducted on male albino rabbits, they were divided in three groups of ten each and each group received one of the calcium channel blockers- Verapamil, Diltiazem and Nifedipine for three months. At the end of each month the serum T3, T4, TSH levels were evaluated by chemiluminisence.

Results:It was found that on continuous daily administration of calcium channel blockers there was a gradual fall in levels of T3 and T4 with rise in TSH levels in comparison to the control value taken before initiating the drug therapy.

Conclusion: These findings could have potential clinical implications and this study proposes the importance of blood thyroid hormone level follow up in the long-term calcium channel blocker therapy. 


Keywords


Calcium channel blockers, Thyroid gland, T3, T4, TSH

Full Text:

PDF

References


Douglas WW, Rubin RP. Mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulation secretion coupling. J Physiol (Lond.) 1963;167:288.

Ikeda K, Isaka T, Fujioka K, Manome Y, Tojo K. Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists. Int J Endocrinol. 2012;2012:519467.

Eto S, McMillan Wood J, Hutchins M. and Flesischer N. Pituitary calcium uptake and release of ACTH, GH and TSH: effect of verapamil. Am J physiol. 1974;226:1315.

Dreifus JJ and Gran JD. Effects on the isolated neurohypophysis of agents that affect the membrane permeability of calcium. J Physiol 1973;231:96.

Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011 Sep;13(9):687-9.

Barbarino A and Marinis LD. Calcium antagonists and hormone release II. Effects of verapamil on Basal Gonadotrophins Releasing Hormone and thyrotropin releasing hormone. Induced pituitary release in normal Subjects. J Clin Endocrino & Metob 1980;749:51-4.

Shupnik MA, Weck J and Hinkle PM. Thyrotropin (TSH) releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through type Ca2+ channels and protein kinase C. Mol Endocrino. 1996;10(1): 90-9.

Cooper CW, Borosky SA, Farrell PE and Steinsland OS. Effects of the calcium channel activator Bay-K 8644 on in vitro secretion of calcitonin & parathyroid hormone. Endocrinol 1986;118:545-9.

Yamada M, Mori M, Yamaguchi M, Akiyama H, Shiono S, Kobayashi I, Kobayashi S. Thyrotropin-releasing hormone stimulation of thyrotropin secretion is suppressed by calcium ion antagonists that block transmembrane influx and intracellular mobilization of calcium ion in human subjects. J Endocrinol Invest. 1986 Jun;9(3):227-31.

Turnbull FM, Woodward M. Calcium antagonists revisited. J Hypertens 2009;27(6):1121-2.

Wartofsky L, Ingbar SH. Diseases of thyroid. In: Harrison’s Principles of Internal Medicine, New York: McGraw Hill, 1991;1692-1712.

Mittal SR, Mathur AK, Prasad N. Effect of calcium channel blockers on serum levels of thyroid hormones. Int J Cardiol 1993;38:131-2.

Kimura T, Okajima F, Sho K, Kobayashi I, Kondo Y. Thyrotropin-induced H2O2 production in FRTL-5 thyroid cells is mediated not by cAMP, but by Ca++ signaling followed by phospholipase-A2 activation and potentiated by adenosine derivative. Endocrinology. 1995 Jan;136(1):116-23.